Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung Bioepis
Pharma
Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia
Pfizer joined the PD-1xVEGF bispecific race. The FDA approved its first Alzheimer's blood test. Samsung Biologics plans a biosimilar spinoff. And more.
Angus Liu
May 23, 2025 9:00am
CDMO Samsung Biologics telegraphs spinoff of biosim unit
May 22, 2025 11:41am
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Feb 28, 2025 8:45am
J&J sues Samsung Bioepis over Stelara biosimilar agreement
Feb 25, 2025 10:21am
Regeneron loses bid to block Amgen's Eylea biosim, sinking shares
Sep 24, 2024 10:32am
Samsung Biologics' 37% sales surge propelled by biosimilars
Jul 24, 2024 10:56am